ARTICLE | Company News
Merus Labs International, POA Pharma Scandinavia AB, Proximum d.o.o., SPCare Lda sales and marketing update
January 28, 2013 8:00 AM UTC
Merus granted exclusive commercialization and distribution rights for Emselex darifenacin to POA Pharma in Denmark, Norway, Sweden, Finland and Iceland, Proximum in Croatia and SPCare in Portugal. Th...